Having trouble viewing this e-mail? CLICK HERE
Pharm Tech
December 2015
Volume 39, No. 12
VIEW ONLINE ARCHIVE SUBSCRIBE FORWARD Twitter LinkedIn

|Focus|

Mapping a Career Path Forward in Bio/Pharma

Rita C. Peters

Bio/pharma employee dissatisfaction with pay and progress may direct some to new career pathways.
read more

|FORMULATION|

Fixed-Dose Combinations

Adeline Siew, PhD

The advantages of fixed-dose combinations are well recognized but their formulation and manufacture can be a challenge, Stefania Barzanti from IMA Active explains why.
read more

|PEER-REVIEW RESEARCH|

Achieving Balance in Sterile Product Manufacturing

James Agalloco and James Akers

Microorganism lethality requirements for process validation must always be balanced with the need to protect product integrity and patient safety.
read more

PharmTech December Issue
Download on the app store Read the issue online Subscribe or renew your Pharm Tech subscription
advertisement

|REGULATORY WATCH|

New Drugs and New Initiatives Shaped 2015

Jill Wechsler

FDA confirmed quality focus while Congress moved to bolster biomedical innovation.
read more

|SEMISOLIDS QUALITY|

Optimizing Semisolid Dosage Forms

Agnes Shanley

Quality by design, in-vitro release testing, and modern analytical methods are improving understanding and control of these complex formulations.
read more

|ROOM PRESSURIZATION|

Preventing Room Pressurization Failures

Eric Bohn

All openings and potential breaches for air penetration must be considered when designing a cleanroom so that the HVAC system can maintain the desired negative or positive pressure.
read more

|GLOBAL MARKET REPORT|

Market Access Outlook for Canada

Michael J. Kuchenreuther, PhD

The author provides an overview of the key aspects of the current Canadian pharmaceutical market.
read more

|API SYNTHESIS & MANUFACTURING|

Outlook Bright for Branded and Generic Active Ingredients

Cynthia A. Challener

A strong API market is expected in 2016 despite fewer new drug approvals.
read more

|TROUBLESHOOTING|

Determining Biosimilarity

Jennifer Markarian

Analytical methods and functional assays are used to compare molecules and relate characteristics to quality attributes for determining biosimilarity.
read more

|OUTSOURCING OUTLOOK|

CMO Investors Have More Money Than Places to Spend It

Jim Miller

CMO industry consolidation may be frustrated by a dearth of attractive assets.
read more

|ASK THE EXPERT|

Crafting Standard Operating Procedures

Susan J. Schniepp, Andrew Harrison

Susan Schniepp, distinguished fellow, and Andrew Harrison, chief regulatory affairs officer and general counsel, both of Regulatory Compliance Associates, discuss how to write standard operating procedures that hold up to audits.
read more

|VIEWPOINT|

The Search for Job Satisfaction

Rita C. Peters

Employers have work to do to improve job satisfaction and retain qualified workers.
read more

|Webcasts|

Thermal Sintering for Controlled Drug Release of Hydrophilic Drugs

On Demand
Proper drug release of high-dose hydrophilic drugs is a challenge for formulators since both the initial drug burst release, as well as the consequent sustained release, need to be controlled. Excipients can provide an answer to drug release challenges when their hydrophobic nature is coupled with thermal sintering. This approach intensifies the retardation of drug release by forming plastic matrices of high mechanical strength, which can withstand dose dumping and achieve controlled release. In this webcast, a formulation expert will discuss BASF's Kolliwax grades and their suitability for thermal sintering; describe how high-dose hydrophilic actives were selected to demonstrate the efficacy of thermal sintering (60-65% w/w) using Kolliwax grades; and present processing parameters to enable customers to reproduce controlled drug release of hydrophilic drugs using thermal sintering.
Sponsored by BASF


Monoclonal Antibody Purification by Protein A Affinity and Hydroxyapatite Mixed Mode: Multi-Column Continuous Chromatography

On Demand
Join Tosoh Bioscience and Semba Biosciences for a discussion on the use of high capacity protein A and hydroxyapatite resins for mAb purification using a multi-column continuous chromatography process.
Sponsored by Tosoh Bioscience


more webcasts
 

|on pharmtech tv|

Tablet Coating

Blow Fill Seal for Aseptic Processing

Cell Therapies

|Events|

InformEX USA 2016

February 2, 2016–February 4, 2016 | New Orleans, LA

2016 PDA Annual Meeting

March 14, 2016–March 16, 2016 | San Antonio, TX

Global Drug Delivery and Formulation Summit

May 23, 2016–May 25, 2016 | Berlin, Germany


more events
 
Contribute an article | contact the editors | contact sales | subscribe | advertise